Saikosaponin D CAS: 20874-52-6

CAS NO: 20874-52-6
Saikosaponin D
Chemical Name: Saikosaponin D
Molecular Formula: C42H68O13
Formula Weight: 780.99
CAS No.: 20874-52-6
Description Review
Description

Saikosaponin D is a type of triterpene saponin, also known as sanchinoside D. Its molecular formula is C42H68O13, and its molecular weight is 804.98 g/mol. The CAS number for saikosaponin D is 20874-52-6.

Top Ten Keywords and Synonyms:

  1. Saikosaponin D extract
  2. Bupleurum falcatum extract
  3. Anti-inflammatory properties
  4. Antiviral activity
  5. Immunomodulatory effects
  6. Liver-protective effects
  7. Anti-cancer effects
  8. Sanchinoside D
  9. Baicalin
  10. Glycyrrhizin

Health Benefits of Saikosaponin D: Saikosaponin D has been used in traditional Chinese medicine for its anti-inflammatory, antiviral, immunomodulatory, and liver-protective properties. In recent years, studies have investigated the potential therapeutic effects of saikosaponin D in various diseases.

  1. Anti-inflammatory Effects: Studies have shown that saikosaponin D inhibits the production of pro-inflammatory cytokines, such as interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). Saikosaponin D also suppresses the activation of nuclear factor-kappa B (NF-κB), a transcription factor that plays a key role in inflammation. These effects make saikosaponin D a potential treatment for inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and asthma.

  2. Antiviral Activity: Saikosaponin D has been reported to exhibit antiviral activity against several viruses, including hepatitis B virus (HBV), hepatitis C virus (HCV), influenza A virus, and human immunodeficiency virus (HIV). Its antiviral effects are thought to be mediated by its ability to inhibit viral replication and expression of viral genes.

  3. Immunomodulatory Effects: Saikosaponin D has been shown to modulate the immune system by increasing the production of interferon-gamma (IFN-γ) and activating natural killer (NK) cells. Its immunomodulatory effects make it a potential treatment for autoimmune diseases and cancer.

  4. Liver-Protective Effects: Saikosaponin D has been found to have hepatoprotective effects by reducing oxidative stress and inflammation in the liver. It also promotes the regeneration of liver cells and improves liver function.

  5. Anti-Cancer Effects: Saikosaponin D has been reported to exhibit anticancer effects by inducing apoptosis and inhibiting proliferation of cancer cells. Its anticancer effects have been observed in various types of cancer, including breast cancer, colon cancer, and lung cancer.

Product Mechanism: Saikosaponin D exerts its therapeutic effects through multiple mechanisms. It modulates various signaling pathways involved in inflammation, oxidative stress, and apoptosis. Saikosaponin D inhibits the activation of NF-κB, a transcription factor that regulates the expression of genes involved in inflammation and immune responses. It also activates Nrf2 (nuclear factor erythroid 2-related factor 2), a transcription factor that upregulates the expression of antioxidant and cytoprotective genes. Saikosaponin D also modulates the activity of enzymes involved in phase I and II detoxification, which helps to eliminate toxins and carcinogens from the body.

Safety and Side Effects: Saikosaponin D is generally considered safe when used as directed. However, high doses or prolonged use may cause gastrointestinal upset, headache, dizziness, and allergic reactions. Saikosaponin D may also interact with certain medications, such as blood thinners and immunosuppressants.

Dosing Information: There is no standard dosing for saikosaponin D because it depends on the condition being treated. However, typical doses range from 50 to 200 mg per day, taken orally.

In Conclusion: Saikosaponin D is a natural compound with promising therapeutic potential. Its anti-inflammatory, antiviral, immunomodulatory, liver-protective, and anticancer properties make it a valuable candidate for the development of new drugs. However, more research is needed to determine its efficacy, safety, and optimal dosing in humans. As with any dietary supplement, it is important to consult a healthcare professional before taking saikosaponin D

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code